JOHN MARAGANORE - 06 Jun 2023 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Director
Signature
By: /s/ Christine Bellon Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
06 Jun 2023
Transactions value $
$0
Form type
4
Filing time
08 Jun 2023, 16:47:04 UTC
Previous filing
03 Feb 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +16.5K $0.00 16.5K 06 Jun 2023 Common Stock 16.5K $34.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of the first anniversary of the date of grant and the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.